Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc has demonstrated a significant increase in revenue, with a projected $249.0 million for 4Q25, signaling an 8.0% quarter-over-quarter growth and a remarkable 76.5% year-over-year increase, outpacing previous estimates. The company's focus on advanced solutions, particularly in PCIe Gen 6 products which accounted for over 20% of total revenue in 3Q25, has led to improved average selling prices (ASP) and robust demand across its Aries, Taurus, and Scorpio product lines. Moreover, the company enjoys strong gross margins that are expected to continue rising, bolstered by the rapid growth in AI infrastructure and server shipments, positioning it favorably in the semiconductor market.

Bears say

Astera Labs Inc's stock outlook is negatively impacted by its dependence on data center infrastructure spending, which is vulnerable to macroeconomic slowdowns in capital investment. Furthermore, the company's revenue derived largely from the United States may be at risk if economic conditions lead to reduced spending in the cloud and AI sectors. Lastly, the overall performance of the semiconductor industry, characterized by cyclical fluctuations, could further exacerbate Astera Labs's financial challenges, influencing its revenue stability and growth.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $200, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $200, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.